Against the backdrop of great expectations from the forthcoming N54.9 trillion Federal Government Budget 2025, the recent reversal of its scheduled passage on February 13, 2025 by the National ...

As one of the leading causes of death worldwide, cancer and its many types have cut many lives short -- some of whom were ...

Tesla's balance sheet strength, with more cash than debt, supports its ability to invest in growth opportunities. Read why ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today ...

Avelumab in combination with axitinib was found effective and safe as frontline treatment for advanced RCC in real-world ...